Viraj Ashok Shinde

Verified @gmail.com

Associate Professor Department of Pharmacology
MIMER MEDICAL COLLEGE TALEGAON

EDUCATION

M.B.B.S. M.D. Pharmacology

RESEARCH, TEACHING, or OTHER INTERESTS

Pharmacology (medical), General Medicine, Pharmacology, Toxicology and Pharmaceutics, Education
1

Scopus Publications

24

Scholar Citations

3

Scholar h-index

1

Scholar i10-index

Scopus Publications

  • Efficacy and safety of oral diclofenac sustained release versus transdermal diclofenac patch in chronic musculoskeletal pain: A randomized, open label trial
    Viraj Ashok Shinde, Mrunalini Kalikar, Satyajeet Jagtap, Ganesh N. Dakhale, Mangesh Bankar, Chaitali S. Bajait, Vijay M. Motghare, Ashlesha A. Pashilkar, Latesh B. Raghute, Ajita D. Khamkar
    Journal of Pharmacology and Pharmacotherapeutics, 2017
    Introduction: To compare the efficacy, safety, and tolerability of transdermal patches of diclofenac sodium with oral diclofenac sustained release (SR) in patients of chronic musculoskeletal MSK pain conditions. Materials and Methods: The eligible patients were given either transdermal diclofenac patch or tablet diclofenac SR. Pain was assessed at 2 and 4 weeks using a visual analog scale. Adverse events were recorded. Patients with 18–65 years old of either gender with score of ≥4 on a 11-item numeric rating scale-numeric version of visual analog scale for pain with diagnosis of primary osteoarthritis (OA) of the knee or hand of at least 3 months duration, with independent radiological confirmation of OA or having pain associated with other MSK conditions such as soft-tissue rheumatism, cervical and lumbar back pain, and fibromyalgia, of at least 3 months duration were included in this study. Results: Transdermal diclofenac diethylamine patch and tablet diclofenac sodium sustained release (SR) do not significantly differ in the reduction of numerical rating scores at the end of 4 weeks (P = 0.8393). Conclusion: Transdermal diclofenac was equi-efficacious as tablet diclofenac sodium SR in reducing pain due to chronic MSK pain conditions.

RECENT SCHOLAR PUBLICATIONS

  • Awareness of health benefits of yoga amon g medical undergraduates: knowledge, attitude & practice based study
    VA Shinde, K Chandaliya, N Kakirde, LB Raghute, P Borkar
    Afr J Biomed Res 27 (3), 2250-55 , 2024
    2024
    Citations: 3
  • Variation of Cost Among Oral Hypoglycaemic Drugs Available in Indian Market in 2020-21.
    RJ Patil, P Borkar, PR Bhandari, VA Shinde
    Indian Journal of Pharmaceutical Sciences 85 (6) , 2023
    2023
  • A pharmacoeconomic outlook of the biological drugs marketed in India: a cost variance analysis
    VA Shinde, R Patil, P Bhandari, P Borkar, S Yadav
    Cureus 15 (1) , 2023
    2023
    Citations: 4
  • Impact of National List of Essential Medicines (NLEM) on Cost Variation of Immunosuppressants available in Indian Market.
    P Borkar, V Shinde, P Bhandari, R Patil
    Journal of Young Pharmacists 14 (3), 311 , 2022
    2022
  • 'Adverse drug Reaction Profile At Radiotherapy, Paediatrics and ear, Nose and Throat Department of A Tertiary Care Teaching Hospital: A descriptive Cross Sectional Study
    G Dakhale, L Raghute, A Turankar, S Pimpalkhute, V Shinde, P Nama
    International Journal of Current Advanced Research 7 (8(H)), 15082-15087 , 2018
    2018
  • Efficacy and safety of oral diclofenac sustained release versus transdermal diclofenac patch in chronic musculoskeletal pain: a randomized, open label trial
    VA Shinde, M Kalikar, S Jagtap, GN Dakhale, M Bankar, CS Bajait, ...
    Journal of Pharmacology and Pharmacotherapeutics 8 (4), 166-171 , 2017
    2017
    Citations: 17
  • Complementary and alternative medicine use in children with haematological disorders
    S Sontakke, V Shinde, VM Motghare, S Pimpalkhute, C Bajait, K Jaiswal
    World Journal of Pharmaceutical Sciences 4 (10), 43-49 , 2016
    2016

MOST CITED SCHOLAR PUBLICATIONS

  • Efficacy and safety of oral diclofenac sustained release versus transdermal diclofenac patch in chronic musculoskeletal pain: a randomized, open label trial
    VA Shinde, M Kalikar, S Jagtap, GN Dakhale, M Bankar, CS Bajait, ...
    Journal of Pharmacology and Pharmacotherapeutics 8 (4), 166-171 , 2017
    2017
    Citations: 17
  • A pharmacoeconomic outlook of the biological drugs marketed in India: a cost variance analysis
    VA Shinde, R Patil, P Bhandari, P Borkar, S Yadav
    Cureus 15 (1) , 2023
    2023
    Citations: 4
  • Awareness of health benefits of yoga amon g medical undergraduates: knowledge, attitude & practice based study
    VA Shinde, K Chandaliya, N Kakirde, LB Raghute, P Borkar
    Afr J Biomed Res 27 (3), 2250-55 , 2024
    2024
    Citations: 3
  • Variation of Cost Among Oral Hypoglycaemic Drugs Available in Indian Market in 2020-21.
    RJ Patil, P Borkar, PR Bhandari, VA Shinde
    Indian Journal of Pharmaceutical Sciences 85 (6) , 2023
    2023
  • Impact of National List of Essential Medicines (NLEM) on Cost Variation of Immunosuppressants available in Indian Market.
    P Borkar, V Shinde, P Bhandari, R Patil
    Journal of Young Pharmacists 14 (3), 311 , 2022
    2022
  • 'Adverse drug Reaction Profile At Radiotherapy, Paediatrics and ear, Nose and Throat Department of A Tertiary Care Teaching Hospital: A descriptive Cross Sectional Study
    G Dakhale, L Raghute, A Turankar, S Pimpalkhute, V Shinde, P Nama
    International Journal of Current Advanced Research 7 (8(H)), 15082-15087 , 2018
    2018
  • Complementary and alternative medicine use in children with haematological disorders
    S Sontakke, V Shinde, VM Motghare, S Pimpalkhute, C Bajait, K Jaiswal
    World Journal of Pharmaceutical Sciences 4 (10), 43-49 , 2016
    2016